Medical Commercial Bribery Cases Will Be Notified To The Med
Release Time：2020/09/23 Click：
Recently, the Supreme People's Court, the National Medical Insurance Bureau, and the Central Commission for Discipline Inspection have successively issued documents. Multiple information channels show that the fight against pharmaceutical commercial bribery will be promoted from the top-level design, information sharing, strengthened supervision, and in-depth governance!
On September 17, the National Medical Insurance Bureau announced that the Supreme People's Court and the National Medical Insurance Bureau signed the "Memorandum of Cooperation on Information Exchange and Sharing of Commercial Bribery Cases in the Medical Field." The main content is to establish a regular notification system for commercial bribery cases in the pharmaceutical field, actively expand the application of judicial results of commercial bribery cases in the pharmaceutical field in the field of pharmaceutical prices and recruitment, jointly promote information exchange and sharing at all levels of the system, and continue to deepen the governance of commercial bribery in the pharmaceutical field Cooperation.
In accordance with the “Opinions of the Central Committee of the Communist Party of China and the State Council on Deepening the Reform of the Medical Security System”, the National Medical Insurance Administration has been actively promoting the establishment of a medical price and recruitment credit evaluation system. On September 16, the National Medical Insurance Administration issued a Establish and implement a credit evaluation system before the end of the year. Under the cooperation framework of the National Medical Security Administration and relevant departments, take pharmaceutical commercial bribery as the entry point, rely on the centralized pharmaceutical procurement market, increase the control of pharmaceutical commercial bribery, and promote pharmaceutical companies in accordance with the law Operate with integrity, promote the return of reasonable prices of medicines, and better ensure that the people are treated for their diseases.
In answering reporters’ questions, the Price Recruitment and Procurement Department of the National Medical Insurance Administration took the issue of drug rebates as an example. It mentioned some data: “According to the statistics of publicly available court judgments, there were more than 100 compulsory drug companies in the country from 2016 to 2019. Half of them were found to have given or indirectly given rebates. Among them, the most frequent companies involved more than 20 cases in three years, and the rebate amount in a single case exceeded 20 million yuan. The average sales expense ratio of listed pharmaceutical companies exceeded 30%."
It seems that after the Supreme People's Court and the National Medical Insurance Administration have signed a memorandum of cooperation, any such cases will inevitably be included in the medical insurance bureau's corporate credit evaluation, which will directly affect the work of mass procurement.
In addition, on September 18, the official website of the State Supervision Commission of the Central Commission for Discipline Inspection issued an important news "Discipline Inspection and Supervision Organs Strengthen Supervision in the Medical Field, Focusing on Risks and Breaking the Interest Chain." Problem-oriented, comprehensively sort out the risk points and high-risk links in the medical field, resolutely cut the profit chain of corruption in the medical field, and promote the medical industry to eliminate unhealthy trends.
For example, taking the special rectification in Chengdu, Sichuan Province since June as an example, according to the person in charge of the Chengdu Commission for Discipline Inspection and Supervision, the special rectification focuses on private procurement, commissions for billing, excessive use, storage after use, and commercial integration. Fang and other violations of laws and regulations have set up reporting areas on official websites, WeChat public accounts, prominent locations in hospitals, etc. in order to collect clues about problems and rectify chaos in the medical field.